List of Tables
Table 1. Global Non-melanoma Skin Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Imiquimod Cream
Table 3. Key Players of 5-fluorouracil Cream
Table 4. Key Players of Vismodegib
Table 5. Key Players of Cemiplimab
Table 6. Key Players of Cisplatin
Table 7. Key Players of Paclitaxel
Table 8. Global Non-melanoma Skin Cancer Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Non-melanoma Skin Cancer Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Non-melanoma Skin Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Non-melanoma Skin Cancer Drugs Market Share by Region (2019-2024)
Table 12. Global Non-melanoma Skin Cancer Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Non-melanoma Skin Cancer Drugs Market Share by Region (2025-2030)
Table 14. Non-melanoma Skin Cancer Drugs Market Trends
Table 15. Non-melanoma Skin Cancer Drugs Market Drivers
Table 16. Non-melanoma Skin Cancer Drugs Market Challenges
Table 17. Non-melanoma Skin Cancer Drugs Market Restraints
Table 18. Global Non-melanoma Skin Cancer Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Non-melanoma Skin Cancer Drugs Market Share by Players (2019-2024)
Table 20. Global Top Non-melanoma Skin Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-melanoma Skin Cancer Drugs as of 2023)
Table 21. Ranking of Global Top Non-melanoma Skin Cancer Drugs Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Non-melanoma Skin Cancer Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Non-melanoma Skin Cancer Drugs Product Solution and Service
Table 25. Date of Enter into Non-melanoma Skin Cancer Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Non-melanoma Skin Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Non-melanoma Skin Cancer Drugs Revenue Market Share by Type (2019-2024)
Table 29. Global Non-melanoma Skin Cancer Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Non-melanoma Skin Cancer Drugs Revenue Market Share by Type (2025-2030)
Table 31. Global Non-melanoma Skin Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Non-melanoma Skin Cancer Drugs Revenue Market Share by Application (2019-2024)
Table 33. Global Non-melanoma Skin Cancer Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Non-melanoma Skin Cancer Drugs Revenue Market Share by Application (2025-2030)
Table 35. North America Non-melanoma Skin Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Non-melanoma Skin Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Non-melanoma Skin Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Non-melanoma Skin Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Non-melanoma Skin Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Non-melanoma Skin Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Non-melanoma Skin Cancer Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Non-melanoma Skin Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Non-melanoma Skin Cancer Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Non-melanoma Skin Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Non-melanoma Skin Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Non-melanoma Skin Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Non-melanoma Skin Cancer Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Non-melanoma Skin Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Non-melanoma Skin Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 50. Pfizer Company Detail
Table 51. Pfizer Business Overview
Table 52. Pfizer Non-melanoma Skin Cancer Drugs Product
Table 53. Pfizer Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 54. Pfizer Recent Development
Table 55. Bausch Health Company Detail
Table 56. Bausch Health Business Overview
Table 57. Bausch Health Non-melanoma Skin Cancer Drugs Product
Table 58. Bausch Health Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 59. Bausch Health Recent Development
Table 60. Mayne Pharma Company Detail
Table 61. Mayne Pharma Business Overview
Table 62. Mayne Pharma Non-melanoma Skin Cancer Drugs Product
Table 63. Mayne Pharma Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 64. Mayne Pharma Recent Development
Table 65. Roche Company Detail
Table 66. Roche Business Overview
Table 67. Roche Non-melanoma Skin Cancer Drugs Product
Table 68. Roche Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 69. Roche Recent Development
Table 70. United Laboratories Company Detail
Table 71. United Laboratories Business Overview
Table 72. United Laboratories Non-melanoma Skin Cancer Drugs Product
Table 73. United Laboratories Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 74. United Laboratories Recent Development
Table 75. 3M Company Detail
Table 76. 3M Business Overview
Table 77. 3M Non-melanoma Skin Cancer Drugs Product
Table 78. 3M Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 79. 3M Recent Development
Table 80. Perrigo Company Detail
Table 81. Perrigo Business Overview
Table 82. Perrigo Non-melanoma Skin Cancer Drugs Product
Table 83. Perrigo Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 84. Perrigo Recent Development
Table 85. Biological E. Company Detail
Table 86. Biological E. Business Overview
Table 87. Biological E. Non-melanoma Skin Cancer Drugs Product
Table 88. Biological E. Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 89. Biological E. Recent Development
Table 90. Glenmark Pharmaceuticals Company Detail
Table 91. Glenmark Pharmaceuticals Business Overview
Table 92. Glenmark Pharmaceuticals Non-melanoma Skin Cancer Drugs Product
Table 93. Glenmark Pharmaceuticals Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 94. Glenmark Pharmaceuticals Recent Development
Table 95. Sichuan Med-shine Pharmaceutical Company Detail
Table 96. Sichuan Med-shine Pharmaceutical Business Overview
Table 97. Sichuan Med-shine Pharmaceutical Non-melanoma Skin Cancer Drugs Product
Table 98. Sichuan Med-shine Pharmaceutical Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 99. Sichuan Med-shine Pharmaceutical Recent Development
Table 100. Henan Topfond Pharmaceutical Company Detail
Table 101. Henan Topfond Pharmaceutical Business Overview
Table 102. Henan Topfond Pharmaceutical Non-melanoma Skin Cancer Drugs Product
Table 103. Henan Topfond Pharmaceutical Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 104. Henan Topfond Pharmaceutical Recent Development
Table 105. Regeneron (Sanofi) Company Detail
Table 106. Regeneron (Sanofi) Business Overview
Table 107. Regeneron (Sanofi) Non-melanoma Skin Cancer Drugs Product
Table 108. Regeneron (Sanofi) Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 109. Regeneron (Sanofi) Recent Development
Table 110. Bristol-Myers Squibb Company Detail
Table 111. Bristol-Myers Squibb Business Overview
Table 112. Bristol-Myers Squibb Non-melanoma Skin Cancer Drugs Product
Table 113. Bristol-Myers Squibb Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 114. Bristol-Myers Squibb Recent Development
Table 115. Sun Pharma Company Detail
Table 116. Sun Pharma Business Overview
Table 117. Sun Pharma Non-melanoma Skin Cancer Drugs Product
Table 118. Sun Pharma Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 119. Sun Pharma Recent Development
Table 120. Qilu Pharmaceutical Company Detail
Table 121. Qilu Pharmaceutical Business Overview
Table 122. Qilu Pharmaceutical Non-melanoma Skin Cancer Drugs Product
Table 123. Qilu Pharmaceutical Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 124. Qilu Pharmaceutical Recent Development
Table 125. Hansoh Pharma Company Detail
Table 126. Hansoh Pharma Business Overview
Table 127. Hansoh Pharma Non-melanoma Skin Cancer Drugs Product
Table 128. Hansoh Pharma Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 129. Hansoh Pharma Recent Development
Table 130. Celgene Corporation Company Detail
Table 131. Celgene Corporation Business Overview
Table 132. Celgene Corporation Non-melanoma Skin Cancer Drugs Product
Table 133. Celgene Corporation Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 134. Celgene Corporation Recent Development
Table 135. Taj Accura Company Detail
Table 136. Taj Accura Business Overview
Table 137. Taj Accura Non-melanoma Skin Cancer Drugs Product
Table 138. Taj Accura Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 139. Taj Accura Recent Development
Table 140. Khandelwal Laboratories Pvt Ltd. Company Detail
Table 141. Khandelwal Laboratories Pvt Ltd. Business Overview
Table 142. Khandelwal Laboratories Pvt Ltd. Non-melanoma Skin Cancer Drugs Product
Table 143. Khandelwal Laboratories Pvt Ltd. Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 144. Khandelwal Laboratories Pvt Ltd. Recent Development
Table 145. Luye Pharma Company Detail
Table 146. Luye Pharma Business Overview
Table 147. Luye Pharma Non-melanoma Skin Cancer Drugs Product
Table 148. Luye Pharma Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 149. Luye Pharma Recent Development
Table 150. Beijing Youcare Company Detail
Table 151. Beijing Youcare Business Overview
Table 152. Beijing Youcare Non-melanoma Skin Cancer Drugs Product
Table 153. Beijing Youcare Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 154. Beijing Youcare Recent Development
Table 155. Beijing Union Pharmaceutical Factory Company Detail
Table 156. Beijing Union Pharmaceutical Factory Business Overview
Table 157. Beijing Union Pharmaceutical Factory Non-melanoma Skin Cancer Drugs Product
Table 158. Beijing Union Pharmaceutical Factory Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 159. Beijing Union Pharmaceutical Factory Recent Development
Table 160. Hainan Haiyao Company Detail
Table 161. Hainan Haiyao Business Overview
Table 162. Hainan Haiyao Non-melanoma Skin Cancer Drugs Product
Table 163. Hainan Haiyao Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 164. Hainan Haiyao Recent Development
Table 165. Chuntch Company Detail
Table 166. Chuntch Business Overview
Table 167. Chuntch Non-melanoma Skin Cancer Drugs Product
Table 168. Chuntch Revenue in Non-melanoma Skin Cancer Drugs Business (2019-2024) & (US$ Million)
Table 169. Chuntch Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-melanoma Skin Cancer Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Non-melanoma Skin Cancer Drugs Market Share by Type: 2023 VS 2030
Figure 3. Imiquimod Cream Features
Figure 4. 5-fluorouracil Cream Features
Figure 5. Vismodegib Features
Figure 6. Cemiplimab Features
Figure 7. Cisplatin Features
Figure 8. Paclitaxel Features
Figure 9. Global Non-melanoma Skin Cancer Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Non-melanoma Skin Cancer Drugs Market Share by Application: 2023 VS 2030
Figure 11. Basal Cell Carcinoma (BCC) Case Studies
Figure 12. Squamous Cell Carcinoma (SCC) Case Studies
Figure 13. Non-melanoma Skin Cancer Drugs Report Years Considered
Figure 14. Global Non-melanoma Skin Cancer Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Non-melanoma Skin Cancer Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Non-melanoma Skin Cancer Drugs Market Share by Region: 2023 VS 2030
Figure 17. Global Non-melanoma Skin Cancer Drugs Market Share by Players in 2023
Figure 18. Global Top Non-melanoma Skin Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-melanoma Skin Cancer Drugs as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Non-melanoma Skin Cancer Drugs Revenue in 2023
Figure 20. North America Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Non-melanoma Skin Cancer Drugs Market Share by Country (2019-2030)
Figure 22. United States Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Non-melanoma Skin Cancer Drugs Market Share by Country (2019-2030)
Figure 26. Germany Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Non-melanoma Skin Cancer Drugs Market Share by Region (2019-2030)
Figure 34. China Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Non-melanoma Skin Cancer Drugs Market Share by Country (2019-2030)
Figure 42. Mexico Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Non-melanoma Skin Cancer Drugs Market Share by Country (2019-2030)
Figure 46. Turkey Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Non-melanoma Skin Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Pfizer Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 49. Bausch Health Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 50. Mayne Pharma Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 52. United Laboratories Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 53. 3M Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 54. Perrigo Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 55. Biological E. Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 56. Glenmark Pharmaceuticals Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 57. Sichuan Med-shine Pharmaceutical Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 58. Henan Topfond Pharmaceutical Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 59. Regeneron (Sanofi) Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 60. Bristol-Myers Squibb Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 61. Sun Pharma Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 62. Qilu Pharmaceutical Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 63. Hansoh Pharma Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 64. Celgene Corporation Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 65. Taj Accura Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 66. Khandelwal Laboratories Pvt Ltd. Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 67. Luye Pharma Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 68. Beijing Youcare Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 69. Beijing Union Pharmaceutical Factory Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 70. Hainan Haiyao Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 71. Chuntch Revenue Growth Rate in Non-melanoma Skin Cancer Drugs Business (2019-2024)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed